IPO
IPO: Recursion Pharmaceuticals Leverages Therapeutics Discovery With Machine Learning
Recursion Pharmaceuticals Inc. uses machine learning to hunt for new therapies. The company raised $436 million in an upsized initial public offering ...
DISCOVERIES
Here’s What Glycobiologists Are Doing For Cancer Research
Glycobiology crosses many fields including chemistry, biology, medicine, and materials science. Broadly speaking, glycobiology is the study of the str...
STARTUPS
This Startup Targets Transfer RNA (tRNA) Mechanisms
Shape Therapeutics (ShapeTX) is developing a new generation of gene therapies for some of the most daunting genetic. Its RNA technologies leverage mac...
SCIENCE
The Link Between Evolution And Immunotherapy
According to Dr. Francis Collins, evolutionary studies – comparing the development of these systems across animals and organisms – are now...
